Montair Chewable Tablet 5mg

$65.00$125.00

Product Name Montair Chewable Tablet
Active Ingredient Montelukast
Effect
Improvement of symptoms of allergic rhinitis and bronchial asthma
Strength 5mg
Delivery Time 7~14 days
Target Gender Unisex
Manufacturer Cipla Ltd
SKU: N/A Category:
Brand:Cipla

Available Options:

Product Details of Montair Chewable Tablet 5mg

Features of Montair Chewable Tablet


Montair Chewable Tablet is a product that is favored by those who want to prevent bronchial asthma attacks.

Montair Chewable Tablet is a drug with a relatively new mechanism of action and is classified as a leukotriene receptor antagonist.

It blocks the substances that cause itching and inflammation from acting, so it is also recommended for those who cannot control their symptoms with antihistamines.

Another advantage is that you can chew and take without water.

The effect of Montair Chewable Tablet


Montair 5mg interferes with the action of leukotriene, an pro-inflammatory substance, and is effective in preventing bronchial asthma attacks and treating allergic rhinitis.

Please note that asthma does not directly stop seizures. In the event of a seizure, use an inhaler that widens the bronchi.

Duration of action of Montair Chewable Tablet


It is not a type that has an immediate effect, and the effect begins to appear in about 2 to 4 weeks after continuing to take it.

To prevent asthma attacks, continue as directed by your doctor even if you do not have an asthma attack.

Indications for Montair Chewable Tablet


Montair Chewable Tablet improves the following symptoms:

  • Those who want to prevent bronchial asthma attacks
  • Those who are suspected of having bronchial asthma
  • Those who continue to have asthma-like symptoms
  • Those who are suffering from allergic rhinitis

Active ingredient of Montair Chewable Tablet


Contains montelukast sodium as an active ingredient.

This ingredient binds to leukotriene receptors and prevents bronchial contraction so that an inflammation-inducing substance called leukotriene does not work.

Content and content of Montair Chewable Tablet


Each box contains 150 tablets.

Each Montel (chewable) tablet contains 5 mg of Montelukast sodium.

Pharmaceutical company


  • Cipla Ltd.

Cipla is a pharmaceutical company based in India with a history of more than 80 years.
We manufacture cheap AIDS medicines for HIV patients in emerging countries.

Dosage

How to take Montair Chewable Tablet


Usually, take 5 mg (1 tablet) of Montair Chewable Tablet once a day before going to bed.

Please chew it in your mouth, dissolve it in saliva and drink.

It is important to continue taking it for as long as your doctor tells you.

Recommended dose of Montair Chewable Tablet


Asthma attacks can be painful from night to morning and are recommended to be taken before bedtime.

Do not take with alcohol, caffeine drinks, sugary juices, etc. In general, the absorption of medicines may be poor.

Even if your asthma attack disappears, do not stop taking it at your own discretion. If you are taking other medicines, please consult your doctor or pharmacist. There may be cases where you have a bad drink.

Precautions when taking Montair Chewable Tablet


  • Pregnant women, lactating women, newborn babies, etc. may not be able to take this medicine. Be sure to follow your doctor’s instructions.
  • If you take this medicine for a long period of time, please take regular inspections.
  • If you are on long-term steroid therapy or want to reduce or stop steroids by taking this drug, consult your doctor and take it carefully.

Side effects

Main side effects


Gastrointestinal symptoms such as rash, pruritus, somnolence, headache, and diarrhea, abnormal liver function test values, dry mouth, and urinary occult blood have been reported.

If you feel any discomfort after taking this medicine, stop taking it and consult your doctor or pharmacist.

Rare side effects


Rare adverse reactions include anaphylactic shock, fulminant hepatitis, hepatitis, angioedema, toxic epidermal necrolysis, mucocutaneous ocular syndrome, and thrombocytopenia.

Serious symptoms are also included, so if you feel any abnormalities, do not continue at your own discretion and follow your doctor’s instructions.

If you feel that the effects / side effects are strong


If you feel that the side effects are strong, discontinue use and consult a doctor immediately.

It may be necessary to consider drug therapy to replace Montair 5mg and to reexamine the usage and treatment plan.

Precautions for use

People who are careful about taking Montair Chewable Tablet


The following people should be careful in using it.

  • Those who are pregnant, those who wish to become pregnant, those under 5 years old including newborns, please consult your doctor before use .

Caution for combined use of Montair Chewable Tablet


Concomitant precautions are medicines that require caution when taken in combination with Montair 5mg.

Phenobarbital is designated as a concomitant medication.

This medicine is used to treat epilepsy, so if you are undergoing epilepsy treatment, consult your doctor and use it only if the benefits outweigh the risks.

People who should not take Montair Chewable Tablet


The following people cannot use this medicine:

  • Persons with a history of hypersensitivity to the ingredients of Montair Chewable Tablet People who fall under the above may have strong side effects by using this drug.

Storage method and handling precautions

How to store Montair Chewable Tablet


  • Avoid high temperature and humidity, and store at room temperature.
  • Avoid direct sunlight.
  • Do not store with other medicines. There is a risk of deterioration or deformation.

Precautions for handling Montair Chewable Tablet


  • Be careful not to let infants pick it up. It may lead to an unexpected accident.
  • Please use it according to the expiration date.
  • Overdose is strictly prohibited. If you miss a dose, do not take two doses.

Product information

Montair Chewable Tablet product classification


Prescription drugs: Generic drugs

Generic drugs are developed by other pharmaceutical companies using the same active ingredients after the patent period of the new drug has expired, and are strict on the premise that their efficacy and safety are equivalent to those of the new drug. A drug that has passed the test and has been approved by the government.

Montair Chewable Tablet shape / dosage form


  • Oral type chewable lock

Target gender of Montair Chewable Tablet


  • Adult men and women for the treatment of bronchial asthma and chronic bronchitis

Other Allergy Relief products

Shipping / Packing

Country of shipment


  • India

The sender’s name is not the name of the “lifetimePills”.
Only the name of the shipping country is listed, or the name of the shipping country vendor.
Please note that in most cases, the name of the shipping country will be stated when posting the absentee slip.

Since the product name and drug name of the order will not be printed on the outer box, the contents can be received without the delivery staff or family members knowing the contents.

Click here for details on the packing status
>> About packing

Pack Size

150 Tablets, 300 Tablets

Brand

Cipla

About Cipla (Pharmaceutical company)


Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions. Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world. For over eight decades, making a difference to patients has inspired every aspect of Cipla’s work. Our paradigm-changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of Caring for Life and deep-rooted community links wherever it is present, make it a partner of choice for global health bodies and stakeholders.
Company Name Cipla
location Mumbai, India
Year of establishment 1935
Representative Umang Vohra (CEO)
Official Website https://www.cipla.com/
Cipla Logo

Reviews

There are no reviews yet.

Be the first to review “Montair Chewable Tablet 5mg”

Your email address will not be published. Required fields are marked *

Shopping Cart